NYSE:TLYSTilly's Stock Price, Forecast & News

Tilly's' stock was trading at $4.67 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TLYS stock has increased by 6.0% and is now trading at $4.95. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Tilly's.

Tilly's is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for Tilly's.

Tilly's will be holding an earnings conference call on Wednesday, June 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Tilly's Inc (NYSE:TLYS) issued its earnings results on Thursday, March, 12th. The specialty retailer reported $0.21 EPS for the quarter, topping the Zacks' consensus estimate of $0.20 by $0.01. The specialty retailer earned $172.50 million during the quarter, compared to analyst estimates of $172.43 million. Tilly's had a return on equity of 13.58% and a net margin of 3.65%. The company's revenue for the quarter was up 1.1% on a year-over-year basis. During the same period last year, the business earned $0.27 EPS. View Tilly's' earnings history.

Tilly's announced a dividend on Friday, January 24th. Shareholders of record on Wednesday, February 12th will be paid a dividend of $1.00 per share on Wednesday, February 26th. The ex-dividend date is Tuesday, February 11th. View Tilly's' dividend history.

Tilly's updated its first quarter 2020 After-Hours earnings guidance on Friday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $77.3-77.3 million, compared to the consensus revenue estimate of $99.2 million.

3 brokers have issued 12 month price objectives for Tilly's' stock. Their forecasts range from $6.00 to $7.50. On average, they anticipate Tilly's' stock price to reach $6.75 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price. View analysts' price targets for Tilly's.

Press coverage about TLYS stock has trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tilly's earned a daily sentiment score of 1.5 on InfoTrie's scale. They also assigned news headlines about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutTilly's.

Some companies that are related to Tilly's include TJX Companies (TJX), Ross Stores (ROST), GAP (GPS), Foot Locker (FL), Urban Outfitters (URBN), American Eagle Outfitters (AEO), Abercrombie & Fitch (ANF), Buckle (BKE), Childrens Place (PLCE), Zumiez (ZUMZ), Guess? (GES), Designer Brands (DBI), Shoe Carnival (SCVL), Caleres (CAL) and Genesco (GCO). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Chesapeake Energy (CHK), AMC Entertainment (AMC), ADMA Biologics (ADMA), Pennsylvania R.E.I.T. (PEI), Miragen Therapeutics (MGEN), DHT (DHT), Gannett (GCI) and OrganiGram (OGI).

Tilly's trades on the New York Stock Exchange (NYSE) under the ticker symbol "TLYS."

Tilly's' stock is owned by many different institutional and retail investors. Top institutional shareholders include Paradigm Capital Management Inc. NY (6.76%), BlackRock Inc. (5.63%), Emerald Advisers LLC (2.44%), Emerald Mutual Fund Advisers Trust (2.18%), JPMorgan Chase & Co. (2.08%) and AQR Capital Management LLC (1.62%). Company insiders that own Tilly's stock include Bernard Zeichner, Douglas P Collier, Hezy Shaked, Janet Kerr, Jon Kubo, Michael Henry, Seth R Johnson and Tilly Levine. View institutional ownership trends for Tilly's.

TLYS stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, Wells Fargo & Company MN, Acadian Asset Management LLC, Nuveen Asset Management LLC, Mackay Shields LLC, AQR Capital Management LLC, Connor Clark & Lunn Investment Management Ltd., and State Street Corp. Company insiders that have sold Tilly's company stock in the last year include Bernard Zeichner, and Janet Kerr. View insider buying and selling activity for Tilly's.

TLYS stock was purchased by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Yacktman Asset Management LP, Rothschild Investment Corp IL, WINTON GROUP Ltd, JPMorgan Chase & Co., 1492 Capital Management LLC, Systematic Financial Management LP, and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have bought Tilly's stock in the last two years include Douglas P Collier, Hezy Shaked, Michael Henry, and Seth R Johnson. View insider buying and selling activity for Tilly's.

Shares of TLYS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TLYS stock can currently be purchased for approximately $4.95.

Tilly's has a market capitalization of $147.16 million and generates $619.30 million in revenue each year. The specialty retailer earns $22.62 million in net income (profit) each year or $0.78 on an earnings per share basis. Tilly's employs 5,700 workers across the globe.

The official website for Tilly's is www.tillys.com.

Tilly's' mailing address is 10 WHATNEY, IRVINE CA, 92618. The specialty retailer can be reached via phone at 949-609-5599 or via email at [email protected]